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The Sickle Cell Data Collection (SCDC) program collects health information about people with sickle cell 
disease (SCD) to study trends in diagnosis, treatment, and health care utilization in the United States. Georgia 
is one of two states currently participating in this Centers for Disease Control and Prevention initiative.
This brief is part of a series produced using SCDC Georgia data that can inform decision-makers about how 
critical gaps in diagnosis, treatment, and access to care for patients with SCD can be filled through policy 
changes, improved health care practices, and education. This brief focuses on the number of new cases of 
SCD identified between 2004 and 2016 through the state’s newborn screening program. Geography greatly 
impacts access to specialized SCD care. Understanding the distribution of SCD births can inform questions 
related to access, health care utilization, and quality of care during childhood.
How Is Sickle Cell Disease Diagnosed?
Sickle Cell Data 
Collection Program Brief: 
Births in Georgia, 2004-2016
SCD is diagnosed with a blood test. Since early diagnosis and treatment are important, SCD is most often 
diagnosed at birth during routine newborn screening at the hospital, as required in every state. Follow-up 
testing confirms SCD and can identify which specific genetic form of SCD a patient has.
If a newborn has a positive hemoglobin screening result, the American Academy of Pediatrics recommends 
confirmatory testing by 3 months of age. In Georgia, the newborn screening program is run by the Georgia 
Department of Public Health, including initial testing and oversight of follow-up programs. For follow-up of 
positive results, the newborn screening program contracts with Children’s Healthcare of Atlanta for newborns 
with positive test results in the Metro Atlanta counties, while Augusta University provides follow-up for all other 
counties in the state.
The teams report abnormal results to parents and the health care provider listed at birth, ensure timely 
confirmatory testing, and provide education and counseling to families. Confirmatory testing and additional 
testing of other family members for blood disorders are provided free of charge. Confirmed cases are referred 
to the Children 1st program at the Georgia Department of Public Health for determination of eligibility for 
child health intervention services.
Georgia newborn screening records do not capture individuals who move to Georgia from another state or 
country or individuals born with SCD in the state before implementation of universal screening in 1998.
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New Cases of Sickle Cell Disease in Georgia
Georgia’s newest SCDC data shows that 
approximately 155 babies with SCD are born in 
the state each year, with rates staying relatively 
constant from year to year from 2004 through 
2016 (Figure 1). Over 95% of babies born with 
SCD in Georgia are black or African-American, 
meaning that one out of approximately every 295 
black or African-American babies born in Georgia 
from 2004 through 2016 has SCD.
As the map shows in Figure 2, babies with 
SCD are born in almost every county throughout 
Georgia. However, they are not evenly distributed 
throughout the state. Five Metro Atlanta counties 
averaged more than 10 SCD births each year, while 100 counties saw from one to 12 total SCD births over the 
13-year period.
Why Is Geography Important?
SCDC data shows where patients, health care providers, 
and health care facilities are geographically located and 
can help answer questions related to access, health care 
utilization, and quality of care.
By overlaying SCD births in the state with pediatric SCD 
treatment centers, SCDC data highlights geographic 
challenges in gaining access to care, how far patients 
travel for treatment, whether they are seen at the closest 
facilities to their home, the ratio of identified patients to 
services or providers in a given region, and how these 
geographical factors may influence utilization by provider 
type (e.g., emergency department).
For instance, there were 60 SCD births in Muscogee 
County (where Columbus is the county seat) from 2004 
to 2016. But the Columbus area is nearly a two-hour 
drive to the pediatric comprehensive SCD treatment 
center in Atlanta and a four-hour drive to the pediatric 
comprehensive SCD treatment center in Augusta. To 
better serve SCD patients in the Columbus area, the 
Aflac Cancer and Blood Disorders Center of Children’s 
Healthcare of Atlanta opened an outpatient clinic in 
Columbus, with funding from the Piedmont Columbus 
Regional Foundation in March 2019.
At the time of writing, there are two comprehensive pediatric SCD programs in the state, with five associated 
pediatric outreach clinics in middle and south Georgia. There are two additional pediatric SCD treatment 
centers in Macon and Savannah, with plans in progress to increase outreach through specialized community 
health workers in several areas.
Connect with SCDC 
SCDC nationally: www.cdc.gov/ncbddd/hemoglobinopathies/scdc.html
SCDC Georgia: www.ghpc.gsu.edu/project/hemoglobin-disorders-data-coordinating-center
Contact Angela B. Snyder (angiesnyder@gsu.edu) if you would like to use SCDC Georgia data for your 
research or planning.
Figure 1: SCD Births in Georgia by Year, 2004-2016
Figure 2: SCD Births in Georgia 2004-2016 by County 
of Residence (N = 2,019*), with Locations of Sickle Cell 
Specialty Care
*Thirteen births during this period lack addresses and are not represented 
  in the map.
